Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Stopped early · Phase 2
Conditions studied: Head and Neck Squamous Cell Carcinoma
In brief
The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of the study drug, magrolimab in combination with other anticancer therapies in participants with head and neck squamous cell carcinoma (HNSCC).
Key facts
- Study ID
- NCT04854499
- Run by
- Gilead Sciences
- People needed
- 193
- Starts
- 2021-09-07
- Expected to finish
- 2024-10-02
- Last updated by the study team
- 2025-11-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope — Duarte, California, United States
- UCLA Hematology/Oncology — Los Angeles, California, United States
- Stanford Cancer Institute — Palo Alto, California, United States
- Torrance Memorial Physician Network - Cancer Care Associates — Redondo Beach, California, United States
- Providence Medical Foundation — Santa Rosa, California, United States
- Memorial Healthcare System — Hollywood, Florida, United States
- Ocala Oncology Center — Ocala, Florida, United States
- University Center and Blood Center,LLC. — Athens, Georgia, United States
- Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
- Virginia Piper Cancer Center (Alliant Health — Minneapolis, Minnesota, United States
- Washington University of Medicine- Siteman Cancer Center — St Louis, Missouri, United States
- Astera Cancer Care — East Brunswick, New Jersey, United States
- Icahn School of Medicine at Mount Sinai and the Mount Sinai Hospital — New York, New York, United States
- New York Cancer and Blood Specialists — Port Jefferson Station, New York, United States
- Sanford Roger Maris Cancer Center — Fargo, North Dakota, United States
- OU Health Stephenson Cancer Center — Oklahoma City, Oklahoma, United States
- Lancaster General Hospital — Lancaster, Pennsylvania, United States
- Medical University of South Carolina — Charleston, South Carolina, United States
- Avera Cancer Institute — Sioux Falls, South Dakota, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Huntsman Cancer Institute — Salt Lake City, Utah, United States
- St. Vincent's Hospital Sydney — Darlinghurst, New South Wales, Australia
- Macquarie University — Macquarie Park, New South Wales, Australia
- Blacktown Hospital — Westmead, New South Wales, Australia
- Ironwood Cancer and Research Center — Chandler, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.